Bayer AG
XETRA:BAYN
Bayer AG
Net Issuance of Debt
Bayer AG
Net Issuance of Debt Peer Comparison
Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bayer AG
XETRA:BAYN
|
Net Issuance of Debt
€3.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Net Issuance of Debt
$20k
|
CAGR 3-Years
-91%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck KGaA
XETRA:MRK
|
Net Issuance of Debt
-€568m
|
CAGR 3-Years
12%
|
CAGR 5-Years
23%
|
CAGR 10-Years
2%
|
|
MPH Health Care AG
XETRA:93M1
|
Net Issuance of Debt
-€3m
|
CAGR 3-Years
-1 543%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
Net Issuance of Debt
€294.1m
|
CAGR 3-Years
79%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Net Issuance of Debt
-€4.9m
|
CAGR 3-Years
-165%
|
CAGR 5-Years
-80%
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Net Issuance of Debt?
Net Issuance of Debt
3.3B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Net Issuance of Debt amounts to 3.3B EUR.
What is Bayer AG's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 5Y
-29%
The average annual Net Issuance of Debt growth rates for Bayer AG have been -10% over the past three years , -29% over the past five years .